title: Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.
abstract: OBJECTIVE
  To assess the recently proposed preliminary criteria for the classification of Sjögren's syndrome (SS) in a multicentre European study of a new series of clinically defined cases.
  
  
  METHODS
  The criteria included six items: I = ocular symptoms; II = oral symptoms; III = evidence of keratoconjunctivitis sicca; IV = focal sialoadenitis by minor salivary gland biopsy; V = instrumental evidence of salivary gland involvement; VI = presence of autoantibodies. Each centre was asked to provide five patients with primary SS, five with secondary SS, five with connective tissue diseases (CTD) but without SS, and five controls (patients with ocular or oral features that may simulate SS). The preliminary six item classification criteria set was applied to both the SS patients and the non-SS controls, and the performance of the criteria in terms of sensitivity and specificity was tested.
  
  
  RESULTS
  The criteria set was tested on a total of 278 cases (157 SS patients and 121 non-SS controls) collected from 16 centres in 10 countries. At least four of the six items in the criteria set (limiting item VI to the presence of Ro(SS-A) or La(SS-B) antibodies) were present in 79 of 81 patients initially classified as having primary SS (sensitivity 97.5%), but in only seven of 121 non-SS controls (specificity 94.2%). When the presence of item I or II plus any two of items III-V of the criteria set was considered as indicative of secondary SS, 97.3% (71 of 73) of the patients initially defined as having this disorder and 91.8% (45 of 49) of the control patients with CTD without SS were correctly classified.
  
  
  CONCLUSIONS
  This prospective study confirmed the high validity and reliability of the classification criteria for SS recently proposed by the European Community Study Group.
authors.affiliation: Clinical Immunology and Rheumatology Units, University of Pisa, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Vitali
authors.forename: S
authors.initials: S
authors.lastname: Bombardieri
authors.forename: H M
authors.initials: HM
authors.lastname: Moutsopoulos
authors.forename: J
authors.initials: J
authors.lastname: Coll
authors.forename: R
authors.initials: R
authors.lastname: Gerli
authors.forename: P Y
authors.initials: PY
authors.lastname: Hatron
authors.forename: L
authors.initials: L
authors.lastname: Kater
authors.forename: Y T
authors.initials: YT
authors.lastname: Konttinen
authors.forename: R
authors.initials: R
authors.lastname: Manthorpe
authors.forename: O
authors.initials: O
authors.lastname: Meyer
authors.forename: M
authors.initials: M
authors.lastname: Mosca
authors.forename: P
authors.initials: P
authors.lastname: Ostuni
authors.forename: R A
authors.initials: RA
authors.lastname: Pellerito
authors.forename: Y
authors.initials: Y
authors.lastname: Pennec
authors.forename: S R
authors.initials: SR
authors.lastname: Porter
authors.forename: A
authors.initials: A
authors.lastname: Richards
authors.forename: B
authors.initials: B
authors.lastname: Sauvezie
authors.forename: M
authors.initials: M
authors.lastname: Schiødt
authors.forename: M
authors.initials: M
authors.lastname: Sciuto
authors.forename: Y
authors.initials: Y
authors.lastname: Shoenfeld
authors.forename: F N
authors.initials: FN
authors.lastname: Skopouli
authors.forename: J S
authors.initials: JS
authors.lastname: Smolen
authors.forename: F
authors.initials: F
authors.lastname: Soromenho
authors.forename: M
authors.initials: M
authors.lastname: Tishler
authors.forename: M J
authors.initials: MJ
authors.lastname: Wattiaux
mesh_terms: D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000032:analysis; D005260:Female; D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000150:complications; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012469:Salivary Glands / Q000473:pathology; D012680:Sensitivity and Specificity; D012793:Sialadenitis / Q000150:complications; D012859:Sjogren's Syndrome / Q000145:classification* / Q000276:immunology; D014985:Xerophthalmia / Q000150:complications; D014987:Xerostomia / Q000150:complications
chemical_list: D001323:Autoantibodies